Scribd
Upload
477 views

Drug Card Pradaxa

This patient is taking Pradaxa (dabigatran) 150 mg twice daily to reduce their risk of stroke from nonvalvular atrial fibrillation. They have a history of CVA and atrial fibrillation. Pradaxa can cause life-threatening bleeding and other adverse effects like angioedema and hypersensitivity reactions. Nursing implications include monitoring for bleeding, assessing treatment effectiveness via lab tests, and discontinuing Pradaxa before some procedures to reduce bleeding risks. The patient was instructed to take Pradaxa as directed, contact their provider if they experience any bleeding, and notify all healthcare providers of their medication regimen.

Uploaded by

Ben
Copyright
© © All Rights Reserved
Available Formats
Download as PDF, TXT or read online on Scribd
477 views

Drug Card Pradaxa

This patient is taking Pradaxa (dabigatran) 150 mg twice daily to reduce their risk of stroke from nonvalvular atrial fibrillation. They have a history of CVA and atrial fibrillation. Pradaxa can cause life-threatening bleeding and other adverse effects like angioedema and hypersensitivity reactions. Nursing implications include monitoring for bleeding, assessing treatment effectiveness via lab tests, and discontinuing Pradaxa before some procedures to reduce bleeding risks. The patient was instructed to take Pradaxa as directed, contact their provider if they experience any bleeding, and notify all healthcare providers of their medication regimen.

Uploaded by

Ben
Copyright
© © All Rights Reserved
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

Trade Name: Pradaxa

Generic Name: dabigatran

Pt Weight: 96.6kg

Classification: anticoagulant
Indications: To reduce the risk of stroke/systemic embolization associated with nonvalvular
atrial fibrillation
Why is your patient taking this drug? Past history of CVA and Atrial Fibrillation
Standard doses and routes: PO: (Adults) 150 mg twice daily
Patient Dose: same as standard
Adverse Reactions & Side Fx:
GI: abdominal pain, diarrhea, dyspepsia, gastritis, nausea
Hemat: BLEEDING, thrombocytopenia
Misc: ANGIOEDEMA, HYPERSENSITIVITY REACTIONS
INCLUDING ANAPHYLAXIS
* CAPITALS indicate life-threatening.
Italics indicate most frequent.

Patient/Family Teaching:

1. Instruct patient to take


dabigatran as directed.
Take missed doses as
soon as remembered
within 6 hr. If <6 hr until
next dose, skip dose and
take next dose when
Contraindications:
scheduled; do not double
doses. Do not discontinue
Hypersensitivity;
without consulting health
Active pathological bleeding;
care professional. If
Concurrent use of P-glycoprotein (P-gp) inducers;
temporarily discontinued,
Prosthetic heart valves (mechanical or bioprosthetic)
restart as soon as
possible. Store dabigatran
Nursing Implications:
at room temperature. After
opening bottle, use within
1. Monitor patient for signs of bleeding. If bleeding occurs,
4 mo; discard unused
stop drug, investigate cause, and provide supportive
dabigatran after 4 mo.
measures. There is no antidote for dabigatran
2.
Inform patient that they
2. Monitor ECT or aPPT to assess treatment effectiveness
may bleed more easily or
3. Discontinue dabigatran 1 to 2 days before invasive or
longer than usual. Advise
surgical procedures in patients with Creatinine clearance of
patient to notify health care
50ml/min or more and 3 to 5 days in patients with Creatinine
professional immediately if
clearance of less than 50ml/min. Consider longer times for
signs of bleeding (unusual
patients undergoing major surgery, spinal puncture, or
bruising; pink or brown
placement of a spinal or epidural catheter or port, in whom
urine; red or black, tarry
complete hemostasis may be required
stools; coughing up blood;

Trade Name: Pradaxa

Generic Name: dabigatran

Lab Test Considerations: May increase activated partial


thromboplastin time (aPTT), ecarin clotting time (ECT), and
thrombin time

Pt Weight: 96.6kg
stools; coughing up blood;
vomiting blood; pain or
swelling in a joint;
headache; dizziness;
weakness; recurring nose
bleeds; unusual bleeding
from gums; heavier than
normal menstrual bleeding;
dyspepsia; abdominal
pain; epigastric pain)
occur..
3. Advise patient to notify
health care professional of
medication regimen prior
to treatment or surgery.
4. Instruct patient to notify
health care professional of
all Rx or OTC medications,
vitamins, or herbal
products being taken and
consult health care
professional before taking
any new medications.

You might also like